New clinical data on lecanemab to be presented at CTAD conference 2026
· prnewswire.com · popularity 19/100 · 0 similar stories today · Brain & Neuroscience (Discovery & Research)
Read the original at prnewswire.com →
Summary
STOCKHOLM, October 30, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present new clinical and real-world evidence on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer's Disease (CTAD) conference in Boston, November 16-19, 2026. The...
Found in: PR Newswire. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 8.